Bodybuilding Medicine deca, the drug that was approved by the Food and Drug Administration in January for the treatment of Parkinson’s disease, could help prevent the onset of Alzheimer’s.
A clinical trial of a capsule containing 1,000mg of the drug, administered once a day for two months, has shown that it can reduce memory impairment, memory loss and cognitive impairment in people with the disease.
Dr Paul Taggart, who led the trial, said the results were “significant and encouraging”.
The study found that people who took the capsule daily for a week were able to reduce their cognitive impairment by 16 per cent.
Dr Taggard said it was the first study to demonstrate that taking the drug twice daily could improve cognitive performance in people who had been taking it for a long time.
“These results have major implications for our clinical practice,” he said.
“This is the first clinical trial to demonstrate a benefit from taking two capsules daily in patients with Alzheimer’s Disease.”
The trial also showed that people taking the capsules twice daily were able, by 16 weeks, to improve their memory retention.
The drug is used to treat people with mild to moderate Alzheimer’s, but its side effects include nausea and vomiting, difficulty concentrating and memory loss.
It has been used for decades as an alternative to medication for people with dementia.
There are currently no approved treatments for Alzheimer’s and there is no known cure.
Dr Peter Fidler, a neurologist at the University of Toronto, said it would be possible to improve memory by taking capsules three times a day.
“The only thing I can see right now is that it would not be enough to help,” he told ABC News.
“I think it’s probably too early to say, for sure, but it is possible.”
It could be that people would benefit from getting a second dose.”ABC/wiresTopics:science-and-technology,health,research,australia